Home » Newsletters » BioWorld Science

BioWorld Science

July 15, 2019

View Archived Issues

Slt-deficient F. novicida mutant shows attenuation and protects against pneumonic challenge in mice

Allist Pharmaceuticals initiates phase III FLAG study of alflutinib mesylate in NSCLC

EIP Pharma initiates phase II study of neflamapimod in cognitive dysfunction associated with DLB

Recruitment ongoing in phase I study of BI-836880 for the treatment of wAMD

Results presented from phase III EAT2TREAT study of fampridine and acetazolamide

Roche presents interim results from part 1 of FIREFISH study of risdiplam

CD73 target defined for subgroup of AML precision medicine

How mothers drive their offspring to drink

FibroGen reports phase II data for pamrevlumab in patients with DMD

Large-scale mapping uncovers protein interactions

Betta Pharmaceuticals presents BRD4 inhibitors

New CRISPR/Cas9 transgenic mice with mutated F8 gene as a model for the study of hemophilia A

Mutations in F153S of integrin beta 3 affect integrin and platelet functions

Chiesi Farmaceutici divulges new ROCK1 and ROCK2 inhibitors

Bodyweight-adjusted rivaroxaban treatment in children with acute venous thromboembolism

Chinese researchers divulge IDO1 inhibitors

Galderma describes new mTOR inhibitors

Angex Pharmaceutical discloses protein kinase inhibitors

Remegen's phase II study of RC-18 meets primary endpoint in SLE

Phase III study of niraparib maintenance therapy in first-line ovarian cancer meets primary endpoint

Pivotal Japanese studies of JTZ-951 in CKD anemia meet primary endpoints

FDA issues complete response letter for Farxiga in type 1 diabetes

Prescient initiates phase Ib trial of PTX-100 in advanced malignancies

Capricor presents 6-month data analysis from HOPE-2 trial of CAP-1002 in DMD

Neon Therapeutics reports phase Ib topline data on NEO-PV-01

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...